The reason that LP and other CEOs of fledgling biotechs keep quiet until there's material information to report is because the wolfpack attacks everything a company puts out, regardless of how positive it is, twisting facts and spinning lies. Therefore, to reduce the number of attacks, a CEO reduces the number of interim PRs prior to approval.
Do we need to post the Cramer interview on this again? Certainly, everyone knows AF is Cramer's protégé.